Company Filing History:
4 out of 10 
1 out of 346 
1 out of 1 Years Active: 2013-2019
Title: Innovations of Markus Woischnik
Introduction
Markus Woischnik is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of six patents to his name, Woischnik's work has garnered attention in the scientific community.
Latest Patents
Among his latest patents are the NPR-B agonists, which disclose novel compounds exhibiting NPR-B agonistic activity. These preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds. This innovative approach has the potential to advance therapeutic options in various medical applications.
Career Highlights
Throughout his career, Markus Woischnik has worked with prominent companies such as Shire Orphan Therapies GmbH and Alcon Research, Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Woischnik has collaborated with notable colleagues, including Frank Osterkamp and Heiko Hawlisch. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Markus Woischnik's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical research and therapeutic development.